MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Management of THV Degeneration
By Janarthanan Sathananthan, MD, and S. Jay Mathews, MD
Redo TAVR: Technical Considerations
Key concepts and risk management for procedural planning of redo TAVR.
By David Meier, MD; Stephane Fournier, MD, PhD; and Janarthanan Sathananthan, MBChB, MPH
Ten-Year Follow-Up Reported From a Single-Center Experience With Early TAVR Devices
July 6, 2020—Investigators assessed the clinical outcomes, rate of structural valve deterioration (SVD), and bioprosthetic valve failure (BVF) in patients after transcatheter aortic valve replacement (TAVR) to 10‐year follow‐up in patients treated at St.
